NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Arvinas Inc (NASDAQ: ARVN)
ARVN Technical Analysis
5
As on 9th Jun 2023 ARVN STOCK Price closed @ 24.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 55.17 & Strong Sell for SHORT-TERM with Stoploss of 70.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ARVNSTOCK Price
Open | 24.70 | Change | Price | % |
High | 25.76 | 1 Day | 0.25 | 1.03 |
Low | 23.95 | 1 Week | 1.71 | 7.50 |
Close | 24.50 | 1 Month | -2.52 | -9.33 |
Volume | 402476 | 1 Year | -48.90 | -66.62 |
52 Week High 82.14 | 52 Week Low 21.83 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ARVN Daily Charts |
ARVN Intraday Charts |
Whats New @ Bazaartrend |
ARVN Free Analysis |
|
ARVN Important Levels Intraday
RESISTANCE | 27.99 |
RESISTANCE | 26.87 |
RESISTANCE | 26.18 |
RESISTANCE | 25.49 |
SUPPORT | 23.51 |
SUPPORT | 22.82 |
SUPPORT | 22.13 |
SUPPORT | 21.01 |
ARVN Forecast May 2024
4th UP Forecast | 60.05 |
3rd UP Forecast | 48.65 |
2nd UP Forecast | 41.6 |
1st UP Forecast | 34.56 |
1st DOWN Forecast | 14.44 |
2nd DOWN Forecast | 7.4 |
3rd DOWN Forecast | 0.35 |
4th DOWN Forecast | -11.05 |
ARVN Weekly Forecast
4th UP Forecast | 37.74 |
3rd UP Forecast | 33.49 |
2nd UP Forecast | 30.87 |
1st UP Forecast | 28.24 |
1st DOWN Forecast | 20.76 |
2nd DOWN Forecast | 18.13 |
3rd DOWN Forecast | 15.51 |
4th DOWN Forecast | 11.26 |
ARVN Forecast2024
4th UP Forecast | 144.34 |
3rd UP Forecast | 105.91 |
2nd UP Forecast | 82.15 |
1st UP Forecast | 58.39 |
1st DOWN Forecast | -9.39 |
2nd DOWN Forecast | -33.15 |
3rd DOWN Forecast | -56.91 |
4th DOWN Forecast | -95.34 |
Arvinas Inc ( NASDAQ USA Symbol : ARVN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ARVN Other Details
Segment | EQ | |
Market Capital | 4572447232.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ARVN Address
ARVN Latest News
ARVN Business Profile
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Bayer AG, and Insilico Medicine, Inc. Arvinas, Inc. was incorporated in 2013 and is based in New Haven, Connecticut. Address: 5 Science Park, New Haven, CT, United States, 06511
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service